XML 41 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share
6 Months Ended
Jun. 30, 2021
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
Note 12 – Earnings Per Share
The following table summarizes earnings per share calculations
 
for the three and six months ended June 30, 2021 and 2020:
Three Months Ended
 
Six Months Ended
June 30,
 
June 30,
 
2021
2020
2021
2020
Basic earnings (loss) per common share
 
 
 
Net income (loss) attributable to Quaker Chemical Corporation
$
 
33,570
$
(7,735)
$
 
72,185
$
(36,116)
Less: (income) loss allocated to participating securities
 
(134)
 
37
 
(287)
 
146
Net income (loss) available to common shareholders
$
 
33,436
$
(7,698)
$
 
71,898
$
(35,970)
Basic weighted average common shares outstanding
17,802,366
17,697,496
17,793,915
17,685,010
Basic earnings (loss) per common share
$
1.88
$
(0.43)
$
4.04
$
(2.03)
Diluted earnings (loss) per common share
Net income (loss) attributable to Quaker Chemical Corporation
$
33,570
$
(7,735)
$
 
72,185
$
(36,116)
Less: (income) loss allocated to participating securities
(134)
 
37
 
(287)
 
146
Net income (loss) available to common shareholders
$
33,436
$
(7,698)
$
71,898
$
(35,970)
Basic weighted average common shares outstanding
17,802,366
17,697,496
17,793,915
17,685,010
Effect of dilutive securities
47,155
52,095
Diluted weighted average common shares outstanding
17,849,521
17,697,496
17,846,010
17,685,010
Diluted earnings (loss) per common share
$
1.88
$
(0.43)
$
4.03
$
(2.03)
Certain stock options and restricted stock units are not included
 
in the diluted earnings (loss) per share calculation when
 
the effect
would have been anti-dilutive.
 
The calculated amount of anti-diluted shares not included
 
was
6,793
 
and
2,952
 
for the three and six
months ended June 30, 2021,
 
respectively.
 
All of the Company’s potentially
 
dilutive shares for the three and six months ended June
30, 2020 are anti-dilutive and not included in the dilutive
 
loss per share calculations because of the Company’s
 
net loss during the
periods.